|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,592.00 INR | +1.52% |
|
-1.12% | +8.09% |
| Capitalization | 1,75000Cr 2.02TCr 1.75TCr 1.65TCr 1.5TCr 2.78TCr 3.13TCr 20TCr 7.48TCr 80TCr 7.58TCr 7.42TCr 2,94700Cr | P/E ratio 2025 |
70x | P/E ratio 2026 * | 64.9x |
|---|---|---|---|---|---|
| Enterprise value | 1,71000Cr 1.97TCr 1.71TCr 1.61TCr 1.47TCr 2.71TCr 3.06TCr 19TCr 7.31TCr 78TCr 7.41TCr 7.25TCr 2,88000Cr | EV / Sales 2025 |
16x | EV / Sales 2026 * | 15.6x |
| Free-Float |
47.79% | Yield 2025 |
0.52% | Yield 2026 * | 0.5% |
More valuation ratios
* Estimated data
More news
Last Transcript: Divi's Laboratories Limited
More recommendations
More press releases
| 1 day | +1.52% | ||
| 1 week | -1.12% | ||
| Current month | -0.30% | ||
| 1 month | +2.16% | ||
| 3 months | +13.22% | ||
| 6 months | +12.75% | ||
| Current year | +8.09% |
| 1 week | 6,455.5 |  | 6,702.5 |
| 1 month | 6,455.5 | | 6,862.5 |
| Current year | 4,955 | | 6,862.5 |
| 1 year | 4,395.3 | | 6,862.5 |
| 3 years | 2,730 | | 6,862.5 |
| 5 years | 2,090.05 | | 6,862.5 |
| 10 years | 532.65 | | 6,862.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | 26/11/2009 | |
| Chief Executive Officer | 47 | 04/01/2020 | |
| Director of Finance/CFO | 75 | 20/11/1994 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 47 | 26/11/2009 | |
| Chairman | 74 | 26/11/2009 | |
| Director/Board Member | 67 | 01/10/1994 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.52% | -1.12% | +46.36% | +86.55% | 1.98TCr | ||
| -2.84% | -6.91% | -13.91% | +162.20% | 70TCr | ||
| -0.62% | -4.65% | +1.36% | -11.61% | 36TCr | ||
| -2.58% | -7.83% | -52.12% | +25.00% | 33TCr | ||
| -0.10% | -3.02% | +7.65% | +34.00% | 33TCr | ||
| -0.27% | -3.86% | +3.72% | -14.84% | 25TCr | ||
| -0.34% | -2.34% | +0.59% | +19.15% | 23TCr | ||
| -1.52% | -5.41% | -16.18% | +3.36% | 22TCr | ||
| -0.29% | -3.24% | -39.03% | -6.57% | 20TCr | ||
| -0.10% | -2.00% | -6.63% | +23.27% | 16TCr | ||
| Average | -0.10% | -4.04% | -6.82% | +32.05% | 28.05TCr | |
| Weighted average by Cap. | -0.16% | -4.62% | -12.31% | +48.10% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 9.3TCr 107.37Cr 93Cr 88Cr 80Cr 147.47Cr 166.16Cr 1.04TCr 397.56Cr 4.26TCr 402.89Cr 394.31Cr 16TCr | 11TCr 126.69Cr 109.89Cr 103.51Cr 94Cr 174Cr 196.05Cr 1.23TCr 469.09Cr 5.03TCr 475.37Cr 465.25Cr 18TCr |
| Net income | 2.13TCr 25Cr 21Cr 20Cr 18Cr 34Cr 38Cr 237.71Cr 91Cr 974.79Cr 92Cr 90Cr 3.58TCr | 2.7TCr 31Cr 27Cr 25Cr 23Cr 43Cr 48Cr 301.52Cr 115.39Cr 1.24TCr 116.94Cr 114.45Cr 4.55TCr |
| Net Debt | -3.99TCr -46Cr -40Cr -38Cr -34Cr -63Cr -71Cr -445.24Cr -170.39Cr -1.83TCr -172.67Cr -169Cr -6.71TCr | -3.93TCr -45Cr -39Cr -37Cr -34Cr -62Cr -70Cr -439.28Cr -168.11Cr -1.8TCr -170.36Cr -166.74Cr -6.62TCr |
More financial data
* Estimated data
Employees
9,741
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/25/20 | 6,592.00 ₹ | +1.52% | 5,60,932 |
| 19/25/19 | 6,493.00 ₹ | -0.86% | 2,40,502 |
| 18/25/18 | 6,549.00 ₹ | +0.17% | 4,47,218 |
| 17/25/17 | 6,538.00 ₹ | -2.24% | 3,41,004 |
| 16/25/16 | 6,687.50 ₹ | +0.31% | 1,66,374 |
Delayed Quote NSE India S.E., June 20, 2025 at 05:19 pm IST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
28
Last Close Price
6,592.00INR
Average target price
6,349.31INR
Spread / Average Target
-3.68%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DIVISLAB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition